TABLE 3.
Examples of viral regulators of STAT3a
Virus | Effect on STAT3 | Reference(s) |
---|---|---|
EBV | EBV proteins LMP1, LMP2A, and EBNA2 upregulate STAT3 signaling to promote cell growth/transformation and viral gene expression/latency and inhibit autophagy. STAT3 binds and activates transcription from promoters of LMP1 and EBNA1 in the viral genome. | 37–41, 73, 74, 236–239 |
HBV | HBV X protein promotes STAT3 activation through interaction with JAK1, deregulation of cellular miRNA expression, and induction of reactive oxygen species. HBV infection activates STAT3 through IL-6-dependent pathways. STAT3 activation impacts viral gene expression/replication, cell survival/proliferation, and apoptosis. STAT3 binds and activates transcription from enhancer 1 in the viral genome. | 47–53 |
HPV | HPV E6 upregulates IL-6/STAT3 signaling to promote viral gene expression and tumorigenesis. STAT3 binds the upstream regulatory region in the viral genome. | 240–243 |
Varicella-zoster virus | Varicella-zoster virus upregulates miR-21 to enhance STAT3 signaling, promoting cell survival and virus replication. | 192, 244 |
Rift Valley fever virus | Rift Valley fever virus NSs induces STAT3 activation to promote cell survival and inhibit virus-induced cell death. | 245 |
PEDV | PEDV upregulates EGFR/STAT3 signaling to inhibit type I IFN signaling and promote viral replication. | 55 |
KSHV | KSHV upregulates STAT3 signaling, including through binding of KSHV LANA and RTA to STAT3 and through JAK-dependent pathways. KSHV kaposin B induces monophosphorylation of STAT3 at S727. STAT3 signaling promotes cell transformation, latency, and inflammatory responses and inhibits autophagy. | 43, 75, 141–146, 181 |
KSHV cyclin K binds STAT3 and inhibits growth-suppressive effects of OSM. KSHV encodes miRNAs that inhibit IL-6/IFN-α-induced STAT3 activation/target gene expression. STAT3 inhibition may induce lytic reactivation. | 106, 246, 247 | |
HCV | HCV upregulates STAT3 signaling, including through binding of HCV core to STAT3, upregulation of IL-6, and induction of reactive oxygen species. STAT3 activation deregulates inflammatory responses and promotes cell proliferation/transformation and viral replication. | 63–68 |
HCV blocks STAT3-DNA binding and induces proteasomal degradation of STAT3, inhibiting IFN-α/LIF signaling. | 69, 70 | |
HCMV | HCMV US28 upregulates IL-6/STAT3 signaling to promote cell proliferation/transformation. STAT3 activity is required for efficient viral gene expression/replication. | 71, 193, 248 |
HCMV IE1 binds and sequesters unphosphorylated STAT3 in the nucleus, inhibiting IL-6/STAT3-dependent gene expression and rewiring IL-6 signaling into an IFN-γ-like response. HCMV inhibits STAT3 activation in response to IFN-α/γ. | 71, 72, 249 | |
HIV-1 | HIV-1 Nef and gp120 upregulate soluble factors that activate STAT3, potentially promoting cell survival and deregulating inflammatory responses. HIV-1 induces monophosphorylation of STAT3 at S727. HIV-1 upregulates IL-10/STAT3 signaling in bystander cells to inhibit autophagy. | 76, 156, 180, 250 |
HIV-1 Vif induces proteasomal degradation of STAT3, inhibiting IFN-α signaling. | 251 | |
EV71 | EV71 induces STAT3 activation to inhibit type I IFN signaling and promote viral replication. | 54 |
EV71 induces miRNA-124, which suppresses IL-6/STAT3 signaling to inhibit anti-EV71 activity. EV71 induces proteasomal degradation of STAT3. | 54, 252 | |
RABV | RABV induces miRNA-455, which suppresses SOCS3 and enhances STAT3 activation to promote viral replication. | 253 |
RABV P protein selectively binds IFN-α/OSM-activated STAT3-STAT1 heterodimers to inhibit nuclear accumulation and target gene expression. | 155, 189 | |
IAV | IAV induces STAT3 activation to delay apoptosis. | 254 |
IAV inhibits STAT3 activation in response to IFN-β/IL-6 by upregulating SOCS3 and downregulating IFN receptor. Inhibition of IL-6/STAT3 signaling is associated with disease severity in vivo. | 154, 255 | |
Severe acute respiratory syndrome coronavirus 1 | Severe acute respiratory syndrome coronavirus 1 PLpro promotes STAT3 signaling to upregulate the Egr-1/TGF-β1b fibrotic pathway. | 256 |
Severe acute respiratory syndrome coronavirus 1 reduces STAT3 phosphorylation, potentially promoting apoptosis. | 257 | |
MUV | MUV V protein induces proteasomal degradation of STAT3, inhibiting IL-6/v-Src/STAT3-dependent gene expression. STAT3 antagonism is associated with disease severity in vivo. | 57, 59 |
MEV | MEV V protein binds STAT3, inhibiting IL-6/v-Src/STAT3-dependent gene expression. | 58 |
Tioman virus | Tioman virus V protein binds STAT3, inhibiting IL-6/STAT3-dependent gene expression. | 62 |
PRRSV | PRRSV NSP5 induces proteasomal degradation of STAT3, inhibiting OSM/STAT3-dependent gene expression. | 258 |
Hepatitis E virus | Hepatitis E virus ORF3 disrupts EGF receptor trafficking, inhibiting EGF/STAT3-dependent gene expression. | 259 |
Marburg virus | Marburg virus VP40 inhibits JAK1 phosphorylation, suppressing IL-6-induced STAT3 activation. | 231 |
Human metapneumovirus | Human metapneumovirus inhibits JAK2 phosphorylation, suppressing IL-6/STAT3-dependent gene expression. | 260 |
Adenovirus | Adenovirus inhibits JAK1 phosphorylation, suppressing IL-6/OSM-induced STAT3 activation. | 233 |
Lightface and boldface indicate stimulatory and inhibitory effects, respectively, on STAT3.
TGF-β1, transforming growth factor β1.